01 /What it is
Retatrutide is a synthetic peptide investigated as a triple incretin agonist that engages GIP, GLP-1, and glucagon receptors. It is one of the newer molecules in the incretin co agonist research line.
02 /How it works
In research models, Retatrutide is studied at three receptors simultaneously: GIP, GLP-1, and glucagon. Its mechanism is investigated in incretin pathway research and energy expenditure research.
03 /What researchers explore it for
Researchers have explored Retatrutide in incretin pathway research, in triple agonist receptor research, and in body composition research alongside dual incretin agonists.
04 /Safety and interactions
Research interactions of note include overlapping pathway engagement with other incretin and glucagon receptor agonists. Retatrutide is for laboratory research use only and is not for human consumption. Not medical advice. Not intended to diagnose, treat, cure, or prevent any disease.
05 /Research notes
Compound family: triple incretin (GIP, GLP-1, glucagon) receptor agonists. Frequently compared with Tirzepatide, Semaglutide, and Liraglutide. The Apothify library lists Retatrutide for encyclopedia coverage only.
Related peptides
Tirzepatide · Semaglutide · Liraglutide